Volume 4, Issue 1 (5-2021)
2021, 4(1): 0-0 |
Back to browse issues page
Ethics code: IR.MEDILAM.REC.1398.211
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shams M, Basati G, Tavan H, Kalvandi G, Nourmohammadi H, Naserifar R. Investigate the consequences of coronavirus (COVID 19) and comparison of patients' survival in the world by systematic review and meta-analysis. Journal title 2021; 4 (1)
URL: http://newresearch.medilam.ac.ir/article-1-854-en.html
URL: http://newresearch.medilam.ac.ir/article-1-854-en.html
Morteza Shams , Gholam Basati , Hamed Tavan , Gholamreza Kalvandi , Hassan Nourmohammadi , Razi Naserifar
Zoonotic Diseases Research Center, Ilam University of Medical sciences, Ilam, Iran
Abstract: (2503 Views)
Coronavirus disease 2019 (COVID-19) is known to be affected by underlying diseases of the respiratory system. In this meta-analysis, the keywords of COVID-19, underlying diseases, symptoms, and mortality were searched in national and international databases to obtain the related studies. The inclusion criteria were as follows: interventional, clinical, descriptive and cross-sectional, and studies focusing on COVID-19. This study was conducted based on Preferred Reporting Items for Systematic Reviews and Meta- Analyses protocol. Eighteen studies were selected to be finally analyzed. The mean percentage of mortality was 14% (I2 ¼ 98.9, P<0.001). The most common symptoms were fever (91%, I2¼88.5, P<0.001) and cough (71%, I2¼84.5, P<0.001), and the most frequent underlying diseases were hypertension (41%, I2¼98.9, P<0.001), diabetes mellitus (18%, I2¼88.7, P<0.001) and cardiovascular disease (11%, I2¼87.7, P<0.001). Findings of present study suggest that individuals with underlying diseases have a higher rate of mortality following COVID-19 infection.
Received: 2020/03/10 | Accepted: 2020/03/16 | Published: 2021/05/31
Send email to the proposal executer
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |